On April 9, 2015 Nicholas Galakatos, a member of the Board of Directors of Portola Pharmaceuticals, Inc. informed the company that he does not intend to stand for reelection at the company's 2015 annual meeting of stockholders. He advised the Board that his decision was not related to any disagreement with the Company's operations, policies, or practices. Dr. Galakatos will continue to serve as director and member of the Audit and Compensation Committees until the Company's 2015 Annual Meeting of Stockholders.

Dr. Galakatos joined the Board in 2003.